Seller record · joiandblokes.com

Joi and Blokes

Recorded September 2026 · Standard v1.1

Fails 2 of 8 criteria. S4, compounding disclosure: The site sells compounded GLP-1 treatments and never states that they lack Food and Drug Administration approval. Four pages were read, covering home, about, contact and the terms. 1 more criterion also fails; see the table below.

Telehealth service. Passes 5 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1.

A hormone and metabolic telehealth service selling compounded GLP-1 and GLP-1 with GIP treatments to men and women. Its terms name the pharmacy that fills its orders and the number of locations that pharmacy operates.

Operating entity The footer, the about page, the contact page and the terms were all read, and none of the four prints a legal entity name.

Dispositions

CodeCriterionDispositionWhere it was read
S1Prescriber requirementPASSjoiandblokes.com
S2Prescription gatingNOT VERIFIEDjoiandblokes.com/schedule
S3Pharmacy identificationPASSjoiandblokes.com/terms
S4Compounding disclosureFAILjoiandblokes.com/about
S5Analytical documentationFAILjoiandblokes.com/terms
S6Business addressPASSjoiandblokes.com/contact
S7Price disclosurePASSjoiandblokes.com/about
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1PASSEvery prescription requires a medical consultation with a licensed provider who decides whether to prescribe, and the site names no individual prescriber.Source: joiandblokes.com.
S2NOT VERIFIEDThe medical intake did not resolve, because the scheduling page presents a checkout and login form and an accessibility overlay, and no health question loaded. The check is open.Source: joiandblokes.com/schedule.
S3PASSThe terms name Strive Pharmacy as the filling pharmacy and state that it owns and operates six pharmacy locations in the United States.Source: joiandblokes.com/terms.
S4FAILThe site sells compounded GLP-1 treatments and never states that they lack Food and Drug Administration approval. Four pages were read, covering home, about, contact and the terms.Source: joiandblokes.com/about.
S5FAILNo certificate, lot number or purity figure appears on any of the four pages read.Source: joiandblokes.com/terms.
S6PASSThe contact page prints a street address with a unit number on University Boulevard in Denver, Colorado, headed mailing address.Source: joiandblokes.com/contact.
S7PASSThe about page prints 399 dollars and 199 dollars per month with no account required.Source: joiandblokes.com/about.
S8PASSFDA warning letter 728283, June 2026, names Joi and Blokes at the Denver address this site prints, and cites claims that its compounded product is the same bioidentical compound as an approved brand. No FDA action has halted the business, and the seller still trades.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded GLP-1 treatments, compounded GLP-1 and GIP treatments, hormone therapy, peptide therapy.

Enforcement documents on file: 1 warning letter

FDA warning letter 728283, issued June 2026, to Joi and Blokes dba Joi + BlokesClaims on joiandblokes.com asserting equivalence between its compounded semaglutide and Ozempic and Wegovy are false or misleading.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Unpaid link. Joi and Blokes does not pay the site, and nothing is earned when it is used. Funding.

Visit Joi and Blokes

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.